Hong Kee Kim

410 citations
12 papers · 356 indexed · h-index 7
Topics
Advancements in Transdermal Drug Delivery (7 papers)Dermatology and Skin Diseases (4 papers)Immunotherapy and Immune Responses (2 papers)

In The Last Decade

Hong Kee Kim

12 papers receiving 353 citations

Peers

Hong Kee Kim
Comparison fields: 5 of 52
  • Pharmaceutical Science 234
  • Dermatology 135
  • Immunology 109
  • Molecular Biology 79
  • Biomedical Engineering 57
Replace Shui Zou with:
Shui Zou Singapore
Wanbing Qin China
Jiaxuan Zhao China
Daniel Kupor United States
Maria Dul United Kingdom
Xuan Jin China
Ziad Sartawi Ireland
Sharon W. T. Chew Singapore
Razina Z. Seeni Singapore
Karola Stieler Germany
Hong Kee Kim relative to Shui Zou Singapore Shui Zou's profile →
Citations per field
00.5×1.5×1.8×
Shui Zou · 1×
Citations per year

Countries citing papers authored by Hong Kee Kim

Since Specialization
Citations

This map shows the geographic impact of Hong Kee Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hong Kee Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hong Kee Kim more than expected).

Fields of papers citing papers by Hong Kee Kim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hong Kee Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hong Kee Kim. The network helps show where Hong Kee Kim may publish in the future.

Co-authorship network of co-authors of Hong Kee Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Hong Kee Kim. A scholar is included among the top collaborators of Hong Kee Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hong Kee Kim. Hong Kee Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
#WorkIndexed citations
1 9
2 5
3 27
4 18
5 148
6 39
7 65
8 1
9 6
10 36
11 1
12
A Practical Biosignal-Based Human Interface Applicable to the Assistive Systems for People with Motor Impairment(Rehabilitation Engineering and Assistive Technology)
1

About Hong Kee Kim

Hong Kee Kim is a scholar working on Pharmaceutical Science, Dermatology and Occupational Therapy, having authored 12 papers that have together received 356 indexed citations. Recurring topics across this work include Advancements in Transdermal Drug Delivery (7 papers), Dermatology and Skin Diseases (4 papers) and Immunotherapy and Immune Responses (2 papers). The work is most often cited by research in Pharmaceutical Science (234 citations), Dermatology (135 citations) and Immunology (109 citations). Hong Kee Kim has collaborated with scholars based in South Korea, Canada and Pakistan. Frequent co-authors include Do Hyeon Jeong, Haeshin Lee, Mikyung Shin, Jung Eun Lee, Doo Sung Lee, Sohyun Kim, Jung Dong Kim, Yue Yin, Jong Han Lee and Su Yeon Lim. Their work appears in journals such as ACS Nano, PLoS ONE and Biomaterials.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026